Company page
Castle Biosciences, Inc.
Castle Biosciences, Inc. is a public company traded under the ticker CSTL in the American market. The company has a market capitalization of approximately $640.6 million. Castle Biosciences focuses on developing and commercializing innovative diagnostic tests to improve patient outcomes in oncology.
- Ticker
- CSTL:NASDAQ
- Asset type
- Stock
- Market cap
- $640.6M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD